The company conducts extensive development activities in collaboration with partners in Asia, Europe and India. Our strategy is to develop generic medicines in areas where the competition is limited, so-called niche generics. We do not focus on specific therapeutic areas, but rather on the opportunities we can identify in the Nordic market for prescription medicines sold in pharmacies or used in hospitals.